Have mRNA vaccines sentenced DNA vaccines to death?

A Cagigi, B Douradinha - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction After receiving emergency approval during the COVID-19 pandemic, mRNA
vaccines have taken center stage in the quest to enhance future vaccination strategies for …

Pharmacoequity & Biologics In The Allergy Clinic: Providing The Right Care, At The Right Time, Every time, To Everyone

AE Conway, J Lieberman, CD Codispoti… - The Journal of Allergy …, 2024 - Elsevier
Pharmacoequity refers to equity in access to pharmacotherapy for all patients and is an
especially large barrier to biologic agents in patients with allergic diseases. Value-based …

Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023

X Yang, M Chen, L Cao, M Zhao - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT The Coronavirus Disease 2019 (COVID-19) pandemic has now persisted
globally for four years, resulting in a staggering death toll of over 4 million individuals. The …

[HTML][HTML] Chronic urticaria after Moderna COVID-19 vaccine boosters: A case series

C Ryan, K Li, R Bennett, MJ Davis, M Shaker… - JAAD Case Reports, 2024 - Elsevier
Discussion In the present case series we describe 7 patients, in accordance with the case
reports guidelines, 6 who developed delayed-onset CU 1 to 6 weeks after receiving an …

Right Biceps Pseudo-Tumor from COVID-19 Vaccination

AM Abbas, ML Caicedo, TA Damron - Vaccines, 2024 - mdpi.com
Delayed hypersensitivity reactions (DHRs) have been reported in association with COVID-
19 vaccines, particularly those that are mRNA-based. Classic DHRs result in induration …

COVID-19 and Allergic Diseases: Lessons Learned and Future Priorities

EJ Phillips, M Shaker - The Journal of Allergy and Clinical …, 2023 - jaci-inpractice.org
On May 5, 2023, the Director-General of the World Health Organization (WHO)“with great
hope” declared the end to COVID-19 (coronavirus disease 2019) as a public health …

Single intranasal immunization with a high dose of influenza vector protects against infection with heterologous influenza virus and SARS-CoV-2 in ferrets and …

A Egorov, AA Krokhin, IA Leneva… - … Journal (MIR Journal …, 2024 - scienceopen.com
BACKGROUND: The challenge of vaccine effectiveness against viruses that undergo
constant antigenic changes during evolution is currently being addressed by updating …

[PDF][PDF] Structural Contributory Factors Associated with SARS-CoV-2 Vaccine Hesitancy among African Americans: A Research Brief

T Stephens, T Moore - Glob Acad J Med Sci, 2023 - researchgate.net
In December 2019, several unusual respiratory diseases arose in Wuhan, China. This
spread quickly from Wuhan to other areas and nations, upon which it was determined that a …

Однократная интраназальная иммунизация высокой дозой гриппозного вектора вызывает защитный эффект при заражении гетерологичным вирусом гриппа …

АЮ Егоров, АА Крохин, ИА Ленева… - … Journal (MIR Journal …, 2024 - scienceopen.com
ПРЕДПОСЫЛКИ: Проблема эффективности вакцинации в отношении вирусов,
претерпевающих постоянные антигенные изменения в процессе эволюции, в …

Δερματολογικές εκδηλώσεις από εμβόλια έναντι του SARS-CoV-2

Φ Μπίτσι - 2024 - polynoe.lib.uniwa.gr
Από το Μάρτιο του 2020, όταν και ανακηρύχθηκε επίσημα η πανδημία της νόσου COVID-19,
μέσα σε ένα χρόνο από την ανίχνευσή του SARS-CoV-2 αναπτύχθηκαν αποτελεσματικά …